Y Intercept (Hong Kong) LTD Smith & Nephew PLC Transaction History

Y Intercept (Hong Kong) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$21.55 - $27.43 $572,949 - $729,281	26,587 New	26,587 $725,000
Q2 2023 Aug 14, 2023	BUY	$28.08 - $32.7 $790,704 - $920,799	28,159 New	28,159 $908,000
Q4 2022 Feb 14, 2023	BUY	$22.3 - $27.91 $198,871 - $248,901	8,918 New	8,918 $239,000
Q1 2022 May 16, 2022	SELL	$30.84 - $36.38 $199,874 - $235,778	-6,481 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$31.98 - $37.15 $67,637 - $78,572	-2,115 Reduced 24.6%	6,481 $224,000
Q3 2021 Nov 15, 2021	BUY	$34.34 - $44.17 $295,186 - $379,685	8,596 New	8,596 $295,000

223

30.2M

900

6.6K

Ticker SNN
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 435,348,000
Market Cap $10.6B
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.